You could almost hear the collective sigh of relief from healthcare providers around the country on May 9, 2023. Two days before the end of the public health emergency (PHE), the Drug Enforcement Agency issued a Temporary Rule that extends current flexibilities for telehealth prescribing of controlled substances for another six months. The Temporary Rule […]
Tag Archives: DEA
During the COVID-19 pandemic, the government extended much-needed flexibilities surrounding telehealth to facilitate access to care. Many of these flexibilities were lifesaving. This included allowing the prescription of controlled substances via telehealth to treat substance use disorders and psychiatric conditions. Background Prior to the pandemic, in most instances, a patient required at least one in-person […]